QQ客服 官方微博 反馈留言

	A novel class of apical sodium--dependent bile salt transporter inhibitors: 1-(2,4-bifluorophenyl)-7-dialkylamino-1,8-naphthyridine-3-carboxamides.
	Liu H; Pang G; Ren J; Zhao Y; Wang J.
刊名	Acta Pharm Sin B
	2017
卷号	Vol.7 No.2页码:223-229
关键词	1-(2,4-Bifluorophenyl)-7-dialkylamino-1,8-naphthyridine-3-carboxamides ASBT inhibitors Bile acids Cholesterol-lowering drug NC-1
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2003618
专题	河北省人民医院
作者单位	1.Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. 2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, China. 3.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, China
推荐引用方式 GB/T 7714	Liu H,Pang G,Ren J,et al. A novel class of apical sodium--dependent bile salt transporter inhibitors: 1-(2,4-bifluorophenyl)-7-dialkylamino-1,8-naphthyridine-3-carboxamides.[J]. Acta Pharm Sin B,2017,Vol.7 No.2:223-229.
APA	Liu H,Pang G,Ren J,Zhao Y,&Wang J..(2017).A novel class of apical sodium--dependent bile salt transporter inhibitors: 1-(2,4-bifluorophenyl)-7-dialkylamino-1,8-naphthyridine-3-carboxamides..Acta Pharm Sin B,Vol.7 No.2,223-229.
MLA	Liu H,et al."A novel class of apical sodium--dependent bile salt transporter inhibitors: 1-(2,4-bifluorophenyl)-7-dialkylamino-1,8-naphthyridine-3-carboxamides.".Acta Pharm Sin B Vol.7 No.2(2017):223-229.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。